veritas automata logo
The Crossroads of Innovation: IoT vs. Edge Computing in Clinical Trials

The Crossroads of Innovation: IoT vs. Edge Computing in Clinical Trials

Saurabh Sarkar

Veritas Automata Fabrizio Sgura

Fabrizio Sgura

When we talk about clinical trials, where precision and efficiency are of utmost importance, we must carefully consider how we utilize technology to optimize patient monitoring and data collection.

The global clinical trial market is projected to reach a staggering $77.2 billion by 2026[1], driven by the increasing complexity of diseases and the demand for innovative treatments. Yet despite this exponential growth, traditional methods of data collection and patient monitoring often fall short in meeting the demands of modern trials.

The Great Debate: IoT vs. Edge Computing
As we stand at the crossroads of innovation, a debate rages on: IoT vs. Edge Computing. On one hand, IoT promises seamless connectivity and real-time data analysis, enabling researchers to monitor patients remotely and gather insights with unprecedented speed. On the other hand, Edge Computing offers localized data processing, reducing latency and bandwidth usage, crucial for remote trials in areas with limited connectivity.
Smart Devices: The Game Changer in Patient Monitoring

We look to smart devices—wearables, sensors, and monitors—to transform patient monitoring in clinical trials. These devices, powered by IoT technology, provide real-time data streams, enabling researchers to track vital signs, medication adherence, and symptom progression with incomparable accuracy.

From Data Collection to Analysis: The Edge Advantage

But let’s not discount the power of Edge Computing. With AI/ML capabilities at the edge, localized data processing becomes a necessity. When data is processed and analyzed on-site, it reduces the burden on central servers and ensures timely insights for researchers.

Real-Life Scenarios: Revolutionizing Remote Trials

Consider the case of a remote clinical trial conducted in a rural area with limited internet connectivity. By leveraging Edge Computing with ROS2, researchers are able to deploy localized data processing units, ensuring real-time analysis of patient data without relying on centralized infrastructure. The result? A significant reduction in latency and bandwidth usage, enabling seamless data collection and analysis despite challenging conditions.

Finding the Balance

The debate between IoT and Edge Computing in clinical trials isn’t about choosing one over the other—it’s about finding the right balance.

By harnessing the power of both technologies, researchers can enhance real-time data analysis, reduce latency and bandwidth usage, and ensure data privacy and security in handling sensitive clinical information.

More Insights

Smarter Decisions, Healthier Outcomes: The Role of Business Intelligence in Personalized Healthcare

Thought Leadership
veritas automata arrow

Before the Trial: Using Digital Twins for Preclinical Predictions

Thought Leadership
veritas automata arrow

Quality Assurance at the Speed of Innovation: Kubernetes in Drug Development

Thought Leadership
veritas automata arrow

Lab of the Future: Enhancing Machine-to-Machine Communication with IoT

Thought Leadership
veritas automata arrow

INTERESTED? AVOID A SALES TEAM
AND TALK TO THE EXPERTS DIRECTLY

veritas automata logo white
Veritas Automata logo white
Veritas Automata logo white